Literature DB >> 25869925

Functional Liver Recovery After Bariatric Surgery--a Prospective Cohort Study with the LiMAx Test.

Patrick H Alizai1, Janica Wendl2, Anjali A Roeth3, Christian D Klink4, Tom Luedde5, Inga Steinhoff6, Ulf P Neumann7, Maximilian Schmeding8, Florian Ulmer9.   

Abstract

BACKGROUND: Bariatric surgery provides long-term weight loss and improvement of obesity-associated diseases such as nonalcoholic steatohepatitis (NASH). Histologic improvement of NASH has been reported in some studies after bariatric surgery. This study was designed to assess the liver function in obese patients as well as its recovery after bariatric surgery with a noninvasive test method.
METHODS: In a prospective cohort study from October 2011 to May 2014, morbidly obese individuals receiving bariatric surgery were investigated for functional liver recovery (n = 34). Liver function was determined by the LiMAx test (enzymatic capacity of cytochrome P450 1A2) preoperatively, 6 and 12 months postoperatively. Liver biopsy specimens were obtained from 18 participants and classified according to the nonalcoholic fatty liver disease (NAFLD) activity score (NAS).
RESULTS: The mean age of participants was 44 years, and the mean body mass index (BMI) was 52 kg/m(2). The mean percent excess BMI loss (%EBMIL) was 53 % after 6 months and 68 % after 1 year. Mean liver function capacity increased significantly from 255 μg/kg/h preoperative to 324 μg/kg/h after 6 months and 342 μg/kg/h after 12 months. A negative correlation was observed between %EBMIL and alteration of liver function capacity in the first 6 months. Finally, the median NAS showed a negative correlation with liver function capacity.
CONCLUSIONS: Bariatric surgery leads to a significant functional recovery of the liver. An initial marked weight loss may negatively influence functional liver recovery.

Entities:  

Keywords:  Bariatric surgery; LiMAx; Liver function; Liver regeneration; NAFLD; NASH

Mesh:

Year:  2015        PMID: 25869925     DOI: 10.1007/s11695-015-1664-0

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  45 in total

1.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

Review 2.  Etiopathogenesis of nonalcoholic steatohepatitis.

Authors:  S Chitturi; G C Farrell
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

3.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

4.  Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.

Authors:  Kevin B Barker; Nicole A Palekar; Steven P Bowers; Joel E Goldberg; Joseph P Pulcini; Stephen A Harrison
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

Review 5.  The impact of bariatric surgery on nonalcoholic steatohepatitis.

Authors:  Charlotte Rabl; Guilherme M Campos
Journal:  Semin Liver Dis       Date:  2012-03-13       Impact factor: 6.115

6.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.

Authors:  Pouneh Mofrad; Melissa J Contos; Mahmadul Haque; Carol Sargeant; Robert A Fisher; Velimir A Luketic; Richard K Sterling; Mitchell L Shiffman; Richard T Stravitz; Arun J Sanyal
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

Review 7.  [Quality and quantity in hepatopathology. Diagnostic and clinically relevant grading for non-tumourous liver diseases].

Authors:  T Longerich; C Flechtenmacher; P Schirmacher
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

Review 8.  Physiological and biochemical basis of clinical liver function tests: a review.

Authors:  Lisette T Hoekstra; Wilmar de Graaf; Geert A A Nibourg; Michal Heger; Roelof J Bennink; Bruno Stieger; Thomas M van Gulik
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

9.  Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).

Authors:  Siddharth Verma; Donald Jensen; John Hart; Smruti R Mohanty
Journal:  Liver Int       Date:  2013-06-13       Impact factor: 5.828

10.  Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis.

Authors:  John G Kral; Swan N Thung; Simon Biron; Frederic-Simon Hould; Stefane Lebel; Simon Marceau; Serge Simard; Picard Marceau
Journal:  Surgery       Date:  2004-01       Impact factor: 3.982

View more
  16 in total

1.  Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.

Authors:  Edoardo G Giannini; Claudia Coppo; Chiara Romana; Giovanni B Camerini; Franco De Cian; Nicola Scopinaro; Francesco S Papadia
Journal:  Dig Dis Sci       Date:  2018-04-09       Impact factor: 3.199

2.  Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis.

Authors:  Maximilian Jara; Tomasz Dziodzio; Maciej Malinowski; Katja Lüttgert; Radoslav Nikolov; Paul Viktor Ritschl; Robert Öllinger; Johann Pratschke; Martin Stockmann
Journal:  Dig Dis Sci       Date:  2018-11-07       Impact factor: 3.199

3.  Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.

Authors:  Pierre Eric Danin; Rodolphe Anty; Stephanie Patouraux; Marc Raucoules-Aimé; Jean Gugenheim; Albert Tran; Philippe Gual; Antonio Iannelli
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

Review 4.  Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease.

Authors:  Iraklis Perysinakis; Harilaos C Pappis; Elias Margaris
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

5.  Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS).

Authors:  Mohammad Ali Kalantar Motamedi; Alireza Khalaj; Maryam Mahdavi; Majid Valizadeh; Farhad Hosseinpanah; Maryam Barzin
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

6.  A retrospective case control study identifies peripheral blood mononuclear cell albumin RNA expression as a biomarker for non-alcoholic fatty liver disease.

Authors:  Xin Chu; Kelsey Karasinski; Sean Donellan; Scott Kaniper; G Craig Wood; Weixing Shi; Michael A Edwards; Rohit Soans; Christopher D Still; Glenn S Gerhard
Journal:  Langenbecks Arch Surg       Date:  2019-12-11       Impact factor: 3.445

7.  Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass.

Authors:  Sophia M-T Schmitz; Andreas Kroh; Alexander Koch; Jonathan F Brozat; Christine Stier; Ulf P Neumann; Tom F Ulmer; Patrick H Alizai
Journal:  Obes Surg       Date:  2021-04-04       Impact factor: 4.129

Review 8.  The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease.

Authors:  Jordan J Nostedt; Noah J Switzer; Richdeep S Gill; Jerry Dang; Daniel W Birch; Christopher de Gara; Robert J Bailey; Shahzeer Karmali
Journal:  Can J Gastroenterol Hepatol       Date:  2016-09-29

9.  Impact of liver volume and liver function on posthepatectomy liver failure after portal vein embolization- A multivariable cohort analysis.

Authors:  Patrick H Alizai; Annabel Haelsig; Philipp Bruners; Florian Ulmer; Christian D Klink; Cornelis H C Dejong; Ulf P Neumann; Maximilian Schmeding
Journal:  Ann Med Surg (Lond)       Date:  2017-12-07

10.  Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems.

Authors:  Sophia Marie-Therese Schmitz; Andreas Kroh; Tom Florian Ulmer; Julia Andruszkow; Tom Luedde; Jonathan Frederik Brozat; Ulf Peter Neumann; Patrick Hamid Alizai
Journal:  BMC Gastroenterol       Date:  2020-08-05       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.